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Introduction
Clinically diagnosed diabetes is preceded by a 
long latent period of abnormal glucose metab-
olism (American Diabetes Association 2012). 
In the asymptomatic, nondiabetic range of 
glycemia (< 126 mg/dL) (American Diabetes 
Association 2012), increased fasting blood 
glucose (FBG) levels are already independently 
associated with the development of diabetes 
(Tirosh et al. 2005), cardiovascular disease 
(Duckworth 2001; Levitan et al. 2004; Sarwar 
et al. 2010), and dementia (Crane et al. 2013). 
FBG variations in this range are often under-
appreciated and their potential determinants, 
especially those not directly related to lifestyle, 
are understudied. Ambient particulate matter 
(PM) pollution has recently been suggested 
as an emerging risk factor for metabolic 
disorders including impaired glucose regula-
tion (Esposito et al. 2016; Rajagopalan and 
Brook 2012). Cross-sectional and longitudinal 
studies have revealed that PM is associated 
with increased risk of diabetes (Andersen et al. 
2012; Brook et al. 2008; Puett et al. 2011) 
and with higher levels of markers of insulin 
resistance (Kelishadi et al. 2009). However, the 
relationship between PM and glycemia in the 
nondiabetic range has yet to be studied.
The underlying mechanisms linking PM 
and abnormal glucose regulation are also not 
fully understood. Inflammation is central in 
both PM-associated responses and the patho-
genesis of glucose dysregulation. Evidence 
from previous studies has linked exposures to 
ambient PM with lower DNA methylation in 
inflammatory genes (Bind et al. 2012, 2014). 
DNA methylation, through the addition of a 
methyl group to the 5C position of cytosine 
in the CpG dinucleotide sequence, is a well-
studied epigenetic modification that usually 
silences gene expression (Newell-Price et al. 
2000). Conversely, lower or no methyla-
tion has been associated with upregulated 
gene expression. Lower global methyla-
tion content across the human epigenome 
has been associated with hyperglycemia and 
the up- regulation of inflammatory genes in 
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Background: Among nondiabetic individuals, higher fasting blood glucose (FBG) independently 
predicts diabetes risk, cardiovascular disease, and dementia. Ambient PM2.5 (particulate matter with 
aerodynamic diameter ≤ 2.5 μm) is an emerging determinant of glucose dysregulation. PM2.5 effects 
and mechanisms are understudied among nondiabetic individuals.
oBjectives: Our goals were to investigate whether PM2.5 is associated with an increase in FBG and 
to explore potential mediating roles of epigenetic gene regulation.
Methods: In 551 nondiabetic participants in the Normative Aging Study, we measured FBG, and 
DNA methylation of four inflammatory genes (IFN-γ, IL-6, ICAM-1, and TLR-2), up to four times 
between 2000 and 2011 (median = 2). We estimated short- and medium-term (1-, 7-, and 28-day 
preceding each clinical visit) ambient PM2.5 at each participant’s address using a validated hybrid 
land-use regression satellite-based model. We fitted covariate-adjusted regression models accounting 
for repeated measures.
results: Mean FBG was 99.8 mg/dL (SD = 10.7), 18% of the participants had impaired fasting 
glucose (IFG; i.e., 100–125 mg/dL FBG) at first visit. Interquartile increases in 1-, 7-, and 28-day 
PM2.5 were associated with 0.57 mg/dL (95% CI: 0.02, 1.11, p = 0.04), 1.02 mg/dL (95% CI: 
0.41, 1.63, p = 0.001), and 0.89 mg/dL (95% CI: 0.32, 1.47, p = 0.003) higher FBG, respectively. 
The same PM2.5 metrics were associated with 13% (95% CI: –3%, 33%, p = 0.12), 27% (95% CI: 
6%, 52%, p = 0.01) and 32% (95% CI: 10%, 58%, p = 0.003) higher odds of IFG, respectively. 
PM2.5 was negatively correlated with ICAM-1 methylation (p = 0.01), but not with other genes. 
Mediation analysis estimated that ICAM-1 methylation mediated 9% of the association of 28-day 
PM2.5 with FBG.
conclusions: Among nondiabetics, short- and medium-term PM2.5 were associated with higher 
FBG. Mediation analysis indicated that part of this association was mediated by ICAM-1 promoter 
methylation.
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peripheral leukocytes from patients with type 
2 diabetes mellitus (T2DM) (Luttmer et al. 
2013; Nilsson et al. 2014). Yet, the role of 
methylation of specific genes related to inflam-
mation in mediating the effects of PM on 
FBG has not been investigated.
In a repeated measure study of older men 
in the Greater Boston Area, we investigated the 
association between ambient PM2.5 (PM with 
aerodynamic diameter ≤ 2.5 μm) concentra-
tions at the participants’ addresses—estimated 
over different time windows up to 1 month 
before the visit—and FBG levels among 
nondiabetic participants. Using recently devel-
oped repeated measure mediation analysis, we 
further examined whether and to what extent 
PM2.5 increased FBG through changes in blood 
leukocyte methylation in candidate inflam-
matory genes. We examined methylation of 
inflammatory cytokines [interferon gamma 
(IFN-γ) and interleukin-6 (IL-6)], intercellular 
adhesion molecule-1 (ICAM-1), and Toll-like 
receptor 2 (TLR-2). We hypothesized that 
higher PM2.5 levels associated with increased 
FBG, and part of this association was mediated 
through methylation of inflammatory genes.
Materials and Methods
Study Population
The Normative Aging Study is a prospec-
tive longitudinal cohort established in 1963 
by the U.S. Veterans Administration in the 
Greater Boston area (Power et al. 2011). 
Briefly, participants underwent examina-
tions every 3–5 years. Self-administered 
questionnaires were collected at each visit 
providing information on sociodemographic 
characteristics, medical history, medications, 
and lifestyle. Blood samples were collected 
at each clinical visit, after an overnight fast 
and smoking abstinence (see Figure S2). 
Starting from year 2000, estimated concen-
trations of PM2.5 were obtained from a 
hybrid spatiotemporal prediction model, as 
described in the next section. A total of 656 
participants had complete information on 
PM2.5 measurements from the prediction 
model, FBG, and blood leukocyte DNA 
methylation for at least one and up to four 
visits between 2000 and 2011 (median = 2, 
IQR = 1). We excluded 105 participants 
who, at their first visit, were clinically diabetic 
(FBG ≥ 126 mg/dL at the visit) and were 
taking diabetes medications. Therefore, our 
final study population included 551 partici-
pants. Fifty-two participants were diagnosed 
with diabetes during subsequent visits: For 
these individuals, we retained observations 
from the visit(s) before they were diagnosed 
with diabetes. One hundred and eighty-six 
participants came to just one clinical visit, 
163 participants came to two clinical visits, 
and 202 participants came to three or more 
clinical visits. Participants provided signed 
informed consent at each visit. The study was 
approved by the Institutional Review Boards 
of the participating institutions.
Air Pollution and Temperature
We estimated PM2.5 concentrations at each 
participant’s residential address using a hybrid 
land use regression and satellite-based model 
(Kloog et al. 2012; Madrigano et al. 2013). 
In brief, we utilized MODIS (Moderate 
Resolution Imaging Spectroradiometer) 
satellite-derived aerosol optical depth (AOD) 
measurements to predict daily PM2.5 concen-
tration levels at a 10 km spatial resolution. 
Daily AOD was calibrated using ground PM2.5 
measurements from 78 monitoring stations, 
land use regression and meteorological vari-
ables. To estimate PM2.5 daily concentrations 
in each grid cell, we calibrated the AOD-PM2.5 
relationship using data from grid cells with 
both monitor and AOD values, using mixed 
models with random slopes for day and nested 
regions. In a later stage, we estimated expo-
sures on days when AOD measures were not 
available (e.g., due to cloud cover or snow). 
Model performance was good with high out-
of-sample 10-fold cross-validated R2 (mean 
out-of-sample R2 = 0.83 and 0.81 for days with 
and without available AOD data, respectively) 
(Kloog et al. 2011).
Temperature values were obtained through 
the national climatic data center. Only contin-
uous operating stations that collected data on 
a daily basis were used (26 stations). Grid cells 
were matched to the closest weather station for 
 meteorological variables.
DNA Methylation Measurements
Gene-specific DNA methylation was quan-
tified on buffy-coat DNA using bisulfite 
 polymerase- chain-reaction pyrosequencing 
(Yang et al. 2004). In the Normative Aging 
Study, we generated pyrosequencing-based 
methylation data for nine genes across pathways 
related to oxidation, blood clotting, and 
inflammation (Bind et al. 2012; Lepeule et al. 
2012, 2014). We chose to focus our analysis 
on the four inflammatory genes included in 
these genes, including two inflammatory cyto-
kines (IFN-γ and IL-6), intercellular adhesion 
molecule 1 (ICAM-1), and Toll-like receptor 2 
(TLR-2). The choice of these four inflammatory 
genes was aligned with previous literature on 
PM and inflammation, as well as subclinical 
inflammation and the risk of T2DM (Bind 
et al. 2012; Blüher et al. 2002; Herder et al. 
2013; Madrigano et al. 2010; van Eeden et al. 
2001; Vossoughi et al. 2014). Specifically, 
IFN-γ and IL-6 encode for inflammatory cyto-
kines that facilitate cell-to-cell communications 
in the inflammatory cascade, ICAM-1 encodes 
for a glycoprotein that is often expressed on the 
cell surface of endothelial cells and leukocytes, 
ICAM-1 glycoproteins are important for 
cell surface adhesion, transmigration and 
homing of leukocytes from the circulation to 
the target tissue. TLR-2 encodes for a surface 
receptor protein, which recognizes conserva-
tive molecular patterns and serves as first-line 
defense in innate immunity. DNA methyla tion 
levels were measured for each of these genes 
at two to five CpG sites within the promoter 
region except for IL-6 methylation, which was 
measured within 500 base-pair downstream 
of the gene’s promoter region where nuclear 
respiratory factor-1 (NRF-1) binding sites are 
located (see Figure S1). The methylation of 
NRF-1 region is known to suppress IL-6 gene 
expression (Choi et al. 2004). We calculated 
and used the mean level of position-specific 
DNA methylation for each gene because they 
are highly correlated and are likely to share 
most of the same functional complexes and 
traits, and we assumed that mean methylation 
across the promoter region reflects regional 
epigenetic regulation (Bind et al. 2014).
Fasting Blood Glucose 
Measurement
Blood glucose levels were measured at each 
visit, after an overnight fast and were analyzed 
using the enzymatic hexokinase method. 
According to American Diabetes Association 
criteria, FBG less than 100 mg/dL corresponds 
to normal levels and the 100–125 mg/dL range 
to impaired fasting blood glucose (IFG), which 
in older individuals often progresses to diabetes 
over time. FBG larger than 125 mg/dL is 
defined as clinical diabetes (American Diabetes 
Association 2008, 2012).
Statistical Analysis of the Main 
Association of PM2.5 Levels 
with FBG
We evaluated the association between PM2.5 
levels and FBG (modeled as a continuous 
dependent variable) using linear mixed-effects 
regression with subject-specific intercepts to 
account for the correlation among repeated 
FBG measurements within the same individual. 
Exposure variables included averages of PM2.5 
concentrations for 1-, 7-, and 28-day preceding 
each clinical visit; we considered each moving 
average in a separate regression model. Model 
estimates are expressed per interquartile range 
(IQR) increase in PM2.5 concentration. In the 
models, we adjusted for the following covariates 
selected a priori: age (continuous), body mass 
index [BMI; weight (kg)/height (m)2, contin-
uous], race (white or others), regular patterns 
of physical activity (< 12 hr/week, ≥ 12 and 
< 30 hr/week, ≥ 30 hr/week), smoking status 
(never, former, or current smoker), cumulative 
pack-years of smoking (continuous), alcohol 
consumption (< 2 or ≥ 2 drinks/day), educa-
tion level (high school diploma or less, college 
degree, or graduate degree), statin use (nonuser, 
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current user), temperature (continuous), and 
seasonality. Seasonality was modeled using 
Fourier series terms cos(2π * doy/365.25) and 
sin(2π * doy/365.25), where doy represents 
day of year. We checked the linearity assump-
tions of the continuous covariates using cubic 
splines and found no deviation from linear 
dose response.
In Equation 1, the main regression model 
took the general form:
Yij = β0 + ui + β1X1ij + … + βpXpij 
  + βPM2.5PM2.5 + εij, [1]
where i corresponds to each participant, j to 
the visit; β0 to the intercept for the popula-
tion mean; ui to the subject-specific random 
intercept. β1X1ij to βpXpij correspond to the 
covariates we selected a priori. βPM2.5PM2.5 
corresponds to PM2.5 levels 1-, 7-, or 28-day 
prior to the clinical visits, depending on the 
moving average used in each set of models. εij 
is the within-subject error term.
In a secondary analysis, we considered 
a dichotomized FBG variable for impaired 
fasting glucose (IFG) (categorized using the 
0–100 mg/dL and 100–125 mg/dL ranges) 
as the outcome and evaluated the association 
between PM2.5 and the odds of IFG using 
a logistic regression model with generalized 
estimating equations (GEE) and empirical 
variance estimates to account for repeated 
measurements per subject.
In Equation 2, the logistic regression 
model took the general form:
logit [Pr(Yij = 1)] = β0 + β1Xij + … + βpXij  
  + βPM2.5PM2.5ij, [2]
where i corresponds to each participant, j to 
the visit; β0 to the intercept for the popula-
tion mean. β1Xij to βpXij corresponds to the 
covariates we selected a priori. βPM2.5PM2.5ij 
corresponds to PM2.5 levels 1-, 7-, and 28-day 
prior to the clinical visits, respectively. Yij = 0 
indicates subject i is not defined as IFG at visit 
j; Yij = 1 indicates subject i is IFG at visit j.
To account for potential selection bias due 
to loss of follow-up, we repeated our analyses 
using inverse probability weighting. Specifically, 
in a logistic regression, we predicted the prob-
ability of coming to a subsequent visit based 
on covariates from the previous one, including 
age, BMI, regular patterns of physical activity, 
smoking status, pack-year smoked, FEV1 and 
FVC ratio, medication (diuretics and beta 
blockers), and education level.
Statistical Analysis of DNA 
Methylation and Mediation Analysis
Selection of mediators. We hypothesized that 
associations of PM2.5 with FBG could be 
mediated through changes in gene-specific 
methylation of inflammatory biomarkers. 
We considered the four inflammation 
genes—IFN-γ, IL-6, ICAM-1 and TLR-2—
separately in the mediation analysis. To 
approximate normality of the residuals, we 
used IFN-γ and IL-6 on their original scale 
and log- transformed ICAM-1 and TLR-2.
For DNA methylation of a specific gene 
to be considered as a potential mediator, we 
tested the following criteria a) if there was an 
association between exposure and mediator; 
and b) if there was an association between 
mediator and outcome (Baron and Kenny 
1986; Valeri and Vanderweele 2013). We also 
examined the presence of PM-mediator inter-
actions and found no evidence of interactions 
that changed FBG levels.
Underlying assumptions. To obtain valid 
estimates of the natural indirect effects, we 
adjusted for potential exposure–outcome 
confounders (denoted as C1), exposure–
mediator confounders (denoted as C2), and 
mediator–outcome confounders (denoted as 
C3), which included age, BMI, race, regular 
patterns of physical activity, smoking status, 
cumulative pack-years smoked, alcohol 
consumption, education level, statin use, 
temperature, seasonality, batch of methyla-
tion measurement, percentages of lympho-
cytes, and percentage of neutrophils. We 
assumed no unmeasured confounding for 
a) PM2.5–FBG relation, b) methylation–FBG 
relation, c) PM2.5–methylation relation, after 
fitting the linear mixed-effects models with 
subject-specific intercepts and controlling for 
C1, C2, and C3. In addition, we also assumed 
that no methylation–FBG confounders would 
be affected by PM2.5 exposure.
Due to the longitudinal nature of the 
study, changes in FBG at one visit could 
potentially affect gene-specific methyla-
tion at the subsequent visit [Yij → Mij + 1 
(dotted arrow in Figure 1)]. FBG at one visit 
therefore may serve as a potential mediator-
outcome confounder for the subsequent 
visit and may introduce bias in our estimates 
(Diggle et al. 2013). Therefore, in Equation 
3, we tested the presence of an association 
between Yij and Mij + 1, to check the assump-
tion of time-varying confounding:
Mij + 1 = α0 + ui + α1Yij + … + αpXpij  
  + αPM2.5PM2.5ij + εij, [3]
where i corresponds to each participant 
and j to the visit; α0 to the intercept for the 
population mean; ui to the subject-specific 
random intercept. Mij + 1 corresponds to 
DNA methyla tion at subsequent visit. Yij 
corresponds to FBG measurement. α1X1ij 
to αpXpij correspond to the covariates we 
selected a priori. αPM2.5PM2.5 corresponds 
to PM2.5 levels 1-, 7-, and 28-day prior to 
the clinical visits, respectively. εij is the 
within-subject error term.
Mediation analysis. We fitted two linear 
mixed-effects models with random intercepts 
simultaneously, one modeling the exposure–
mediator association, and one modeling the 
mediator–outcome association (Bauer et al. 
2006; Bind et al. 2016) (Equations 4 and 5):
Mij = β0 + ui + β1X1ij + … + βpXpij  
  + βPM2.5PM2.5ij + εij, [4]
Yij = γ0 + g0i + γ 1X1ij + … + γ pXpij  
  + γ PM2.5PM2.5ij + γ MMij + ηij, [5]
where i corresponds to each participant and j 
to the visit; β0 and γ0 to the intercept for the 
population mean; ui and g0i to the subject-
specific random intercept. β1X1ij to βpXpij 
and γ pXpij to γ pXpij correspond to the covari-
ates we selected a priori. Mij corresponds to 
DNA methylation and Yij corresponds to 
FBG measurement. βPM2.5PM2.5 corresponds 
to PM2.5 levels 1-, 7-, and 28-day prior to the 
clinical visits in the exposure–mediator associ-
ation, and γ MMij corresponds to DNA meth-
ylation in the mediator-outcome association. 
εij and ηij are the within-subject error terms.
Figure 1. Directed acyclic graph (DAG) for mediation analysis.
PM2.5i,j = J represents air pollution exposure for ith subject prior to j = Jth visit; Mi,j = J represents gene-specific DNA 
methyla tion for ith subject at jth visit; Yi,j = J represents fasting blood glucose (FBG) concentrations for ith subject at jth 
visit. C1i,j represents exposure outcome confounders; C2i,j represents exposure mediator confounders; C3i,j represents 
mediator outcome confounders. Note: to be simplified, correlations between repeated measures of exposures (i.e., PM2.5ij 
and PM2.5ij + 1), repeated measures of mediators (i.e., Mij and Mij + 1) and repeated measures of confounders (i.e., Cij and 
Cij + 1) are not shown in this DAG.
Peng et al.
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γ PM2.5 corresponds to the natural direct 
effect, and the natural indirect effect (also 
called “mediated” effect) is given by the 
product of βPM2.5 × γ M. The delta method 
was used to calculate the variance of the 
natural indirect effect, which corresponds to 
Var (γ M) βPM2.52 + 2Cov(βPM2.5, γ M) βPM2.5 
γM + Var(βPM2.5) γ M2. Proportion mediated 
is calculated as the percentage of natural 
indirect effect over the sum of natural direct 
and natural indirect effect (i.e., {[βPM2.5 × 
γ M/(βPM2.5 × γ M + γ PM2.5)]}).
In sensitivity analysis, we tested the robust-
ness of the study findings to the no-unmeasured 
confounding assumptions: a) we excluded 
participants who were current smokers to better 
control for residual confounding by smoking; 
b) we additionally controlled for total calorie 
intake and glycemic index to reduce potential 
mediator–outcome confounding from diet; 
c) we also restricted the analysis to participants 
with a C-reactive protein (CRP) level < 10 mg/L 
to partially remove potential effects from 
acute inflammation.
All analyses were conducted with SAS 
(version 9.3; SAS Institute Inc.), using PROC 
MIXED to fit the linear mixed effect models 
and PROC GENMOD to fit the GEE models.
Results
Descriptive Statistics
A total of 1,152 FBG measurements were 
collected from the 551 nondiabetic partici-
pants in this study. Table 1 describes partici-
pant characteristics at their first visit. Mean 
FBG concentration at the first visit was 
99.8 ± 10.7 mg/dL (mean ± SD) and 18% 
of participants at the first visit had IFG (i.e., 
blood glucose between 100 mg/dL and 
125 mg/dL). Summary statistics of PM2.5 
and temperature during the study period are 
presented in Table S1.
Main Association of PM2.5 Levels 
with FBG
PM 2.5 l e v e l s  we r e  a s so c i a t ed  w i th 
increased FBG (Table 2). For an IQR 
increase in PM2.5 concentration in the 
previous 1-day (IQR = 5.73 μg/m3), 
7-day (IQR = 4.25 μg/m3), and 28-day 
(IQR = 3.12 μg/m3), FBG increased 
0.57 mg/dL [95% confidence inverval (CI): 
0.02, 1.11, p-value = 0.04], 1.02 mg/dL 
(95% CI: 0.41, 1.63, p-value = 0.001), and 
0 .89  mg/dL (95% CI :  0 .32 ,  1 .47 , 
p-value = 0.003), respectively. We also found 
associations of PM2.5 concentrations with IFG 
(i.e., FBG > 100 mg/dL), particularly for the 
longer moving averages of PM2.5 (Table 3). 
IQR increases in PM2.5 in the previous 
1-day (IQR = 5.73 μg/m3), 7-day (IQR 
= 4.25 μg/m3) and 28-day (IQR = 3.12 μg/m3) 
exposure windows were associated with 
OR equal to 1.13 (95% CI: 0.97, 1.33, 
p-value = 0.12), 1.27 (95% CI: 1.06, 1.52, 
p-value = 0.01) and 1.32 (95% CI: 1.10, 1.58, 
p-value = 0.003) for IFG, respectively. We 
also obtained similar estimates when we 
used inverse probability weighting to reduce 
 potential selection bias (see Table S2).
DNA Methylation and Mediation 
Analysis
PM2.5 showed a negative association with 
ICAM-1 methylation, which, in turn, was 
negatively associated with FBG (Figure 2). 
Methylation of IFN-γ, IL-6 and TLR-2 
showed no association with FBG. We also 
found no evidence of PM2.5-mediator inter-
actions that changed FBG levels. Since a 
mediator needs to be associated with both the 
exposure and the outcome (Baron and Kenny 
1986; Valeri and Vanderweele 2013), we 
conducted the analysis of mediation only for 
ICAM-1 methylation. We examined the corre-
lations between ICAM-1 methylation and the 
other three genes and found no substantial 
correlations, which suggests that the separate 
analyses are fairly appropriate.
Table 1. Characteristics of the Normative Aging Study participants included in the analysis, 2000–2011.
Variable Visit 1 Visit 2 Visit 3 Visit 4
Age (years), mean ± SD 73.3 ± 6.9 75.6 ± 6.4 77.9 ± 5.9 78.5 ± 5.8
BMI (kg/m2), mean ± SD 27.8 ± 3.7 27.4 ± 3.7 27.1 ± 3.6 27.5 ± 3.9
Smoking status, n (%)
Never 165 (30%) 112 (31%) 71 (34%) 14 (33%)
Former 363 (66%) 244 (67%) 135 (64%) 1 (2%)
Current 23 (4%) 7 (2%) 5 (2%) 28 (65%)
Pack-years, mean ± SD 19.9 ± 24.7 18.7 ± 23.1 17.1 ± 21.3 16.0 ± 11.5
Race, n (%)
White 543 (97%) 354 (98%) 203 (96%) 42 (98%)
Other 17 (3%) 9 (2%) 8 (4%) 1 (2%)
Metabolic equivalent of task, n (%) 
Low (≤ 12 hr/week) 353 (64%) 222 (61%) 129 (61%) 26 (60%)
Medium (12–30 hr/week) 111 (20%) 89 (25%) 47 (22%) 10 (23%)
High (≥ 30 hr/week) 87 (16%) 52 (14%) 35 (17%) 7 (16%)
Two or more drinks per day, n (%) 102 (19%) 69 (19%) 35 (17%) 4 (9%)
Education, n (%)
< 12 years 181 (33%) 119 (32%) 63 (30%) 11 (26%)
13–16 years 253 (46%) 163 (45%) 98 (46%) 24 (56%)
> 16 years 115 (21%) 81 (22%) 50 (24%) 8 (19%)
Statin use, n (%) 196 (36%) 180 (50%) 122 (58%) 24 (56%)
Fasting blood glucose (mg/dL) 99.8 ± 10.7 98.9 ± 10.0 99.0 ± 10.5 99.0 ± 11.5
Impaired fasting blood glucose, n (%) 100 (18%) 54 (15%) 38 (18%) 7 (16%)
Blood IFN-γ methylation, mean ± SD 84.3 ± 5.9 85.0 ± 4.8 85.3 ± 4.7 85.3 ± 5.5
Blood IL-6 methylation, mean ± SD 43.6 ± 10.3 43.5 ± 10.2 43.8 ± 10.3 42.8 ± 11.5
Blood ICAM methylation, mean ± SD 4.3 ± 1.8 3.9 ± 1.2 4.4 ± 1.2 4.8 ± 1.9
Blood TLR2 methylation, mean ± SD 3.1 ±1.3 3.0 ± 1.4 2.5 ± 1.4 1.9 ± 1.0
Note: Cohort participants with diabetes were excluded.
Table 2. Estimated change (and 95% CI) in fasting blood glucose level (mg/dL) per interquartile range 
increase in PM2.5 concentration averaged over the corresponding time window before each visit.
PM2.5 concentration
Participants 
n
Observations 
n
PM2.5 interquartile 
range (IQR) 
Estimated change (95% CI) 
in FBG per IQR increase in 
PM2.5 concentrations p-Value
1-day moving average 551 1,152 5.71 μg/m3 0.57 (0.02, 1.11) 0.04
7-day moving average 551 1,152 4.28 μg/m3 1.02 (0.41, 1.63) 0.001
28-day moving average 551 1,152 3.09 μg/m3 0.89 (0.32, 1.47) 0.003
Results from linear mixed-effects regression models accounting for correlation across multiple visits and adjusted for 
age, BMI, race, regular patterns of physical activity, smoking status, pack-years smoked, alcohol consumption, educa-
tion level, statin use, temperature, and seasonality. Participants with diabetes were excluded.
Table 3. Odds ratio (and 95% CI) of impaired fasting blood glucose (IFG) per interquartile range (IQR) 
increase in PM2.5 concentration averaged over the corresponding time window before each visit.
PM2.5 concentration
Participants 
n
Observations 
n 
PM2.5 interquartile 
range (IQR) 
Odds ratio (95% CI) of 
IFG per IQR increase in 
PM2.5 concentrations p-Value
1-day moving average 551 1,152 5.73 μg/m3 1.13 (0.97, 1.33) 0.12
7-day moving average 551 1,152 4.25 μg/m3 1.27 (1.06, 1.52) 0.01
28-day moving average 551 1,152 3.12 μg/m3 1.32 (1.10, 1.58) 0.003
Note: IFG is defined as a fasting blood glucose level > 100mg/dL and < 126 mg/dL.
Results from GEE models accounting for correlation across multiple visits and adjusted for age, BMI, race, regular 
patterns of physical activity, smoking status, pack-years smoked, alcohol consumption, education level, statin use, 
temperature, and seasonality. Participants with diabetes were excluded.
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Before conducting the mediation analysis, 
we examined whether FBG levels at one visit 
(Yij) affected ICAM-1 methylation at the subse-
quent visit (Mij + 1) (i.e., FBGij ≥ ICAM-1ij + 1; 
dotted arrow in Figure 1), because it could 
potentially confound the mediator–outcome 
association and bias our estimates (Hernán 
et al. 2004). We found no association between 
Yij (FBGij) and Mij + 1 (ICAM-1ij + 1). Point 
estimates were negligible (see Table S3). When 
we introduced a lag time and examined the 
effect of ICAM-1 methylation on FBG levels in 
the subsequent visit (i.e., ICAM-1ij ≥ FBGij + 1), 
we also did not find an association (point 
estimate = –0.14, 95% CI: –1.93, 1.65).
Table 4 presents the natural direct effect, 
the natural indirect effect, and proportion 
mediated for ICAM-1 methylation over the 
different PM2.5 moving averages. We fitted 
the exposure–mediator and the mediator–
outcome model simultaneously and found 
substantial mediation effects of PM2.5 on FBG 
through a decrease in ICAM methylation 
for the 28-day exposure time window. The 
proportion mediated was larger (9%) for the 
28-day exposure window, but small and negli-
gible for the 1-day and 7-day moving averages.
We conducted further sensitivity analysis 
to examine if our results were robust to the 
no-unmeasured confounding assumptions 
required in the mediation analysis approach 
we used. Specifically, we excluded current 
smokers to limit residual confounding from 
smoking; we additionally controlled for total 
calorie intake and glycemic index to reduce 
potential confounding from diet; and we 
restricted the analysis to participants with 
a CRP level < 10 mg/L to partially remove 
effect from acute inflammation. Proportion 
mediated for ICAM-1 methylation for the 
28-day exposure time window was 9%, 7%, 
and 10%, respectively (see Table S4).
Discussion
In the present study, we showed that PM2.5 
concentrations estimated at the participants’ 
address were associated with higher FBG 
levels among nondiabetic individuals, as well 
as with higher odds of IFG. We also observed 
significant associations of lower blood 
ICAM-1 methylation, which is expected to 
up-regulate the expression of ICAM-1 in 
blood leukocytes, with both higher PM2.5 
levels and higher FBG levels.
Our study is consistent with previous 
epidemiology studies indicating that ambient 
PM is associated with metabolic dysregulation 
(Andersen et al. 2012; Brook et al. 2008; Eze 
et al. 2015; Puett et al. 2011; Rajagopalan 
and Brook 2012). Nevertheless, most 
previous studies either focused on T2DM or 
evaluated blood glucose over its entire range, 
including individuals with diabetes. The non-
diabetic and pre-diabetic population repre-
sents an ideal target for primary prevention, 
which, however, has been understudied in 
air pollution research. Our findings of PM2.5 
associations with FBG in this group may 
help identify individuals who are particularly 
susceptible to changes in FBG in the nondia-
betic range. It is important to notice that the 
small changes in FBG resulted in significant 
odds of IFG, owing to the fact that many 
people are very close to 100 mg/dL in this 
older population, and a very small change in 
FBG may be enough to pass the threshold.
Our mediation analysis suggests that 
ICAM-1 methylation in blood leukocytes 
served as a mediator of the association 
between PM2.5 and FBG, and we observed 
significant mediated effect at 28-day exposure 
time window. Our finding of higher concen-
trations of PM2.5 associated with lower 
methylation of the ICAM-1 gene, which is 
expected to result in higher ICAM-1 expres-
sion, is consistent with previous literature 
indicating that elevated concentrations of 
PM are associated with an increase in expres-
sion of endothelial markers (Bind et al. 2012; 
Madrigano et al. 2010; O’Neill et al. 2007; 
Rückerl et al. 2006). The ICAM-1 glycopro-
tein is responsible for leukocyte adhesion, 
homing, and transmigration during inflam-
matory responses (Rahman and Fazal 2009). 
Exposure to PM2.5 may cause local inflam-
mation in the lungs and promote circulating 
leukocytes in blood to transmigrate to the 
target tissue through the up-regulation of 
adhesion molecules on the endothelial cell 
surface. Recent observational and interven-
tion studies have linked elevated concen-
trations of plasma endothelial adhesion 
molecules with markers of insulin resistance 
and increased risk of T2DM (Blüher et al. 
2002; Hak et al. 2001; Meigs et al. 2004). 
The ICAM-1 glycoprotein may facilitate 
migration of leukocytes from the blood to 
the adipose tissue (Mendez et al. 2013; Rao 
et al. 2015; Sun et al. 2009), which could 
result in local inflammation and subse-
quently insulin resistance. Alternatively, the 
ICAM-1 glycoprotein may also facilitate 
leukocyte transmigration to the pancreas 
Figure 2. Inflammatory candidate gene methylation mediator model of the relationship between PM2.5 concentration and fasting blood glucose level.
ICAM-1 mean and TLR-2 mean DNA methylation is log-normally distributed and IL-6 and IFN-γ are normally distributed. β is the coefficient of the independent variable (PM2.5 28-day 
moving average) when regressing the mediator (candidate gene methylation) on the independent variable, γ is the coefficient of the mediator when regressing the dependent variable 
(FBG) on both the independent variable and the mediator. Results from regression models are adjusted for age, BMI, race, regular patterns of physical activity, smoking status, pack-
years smoked, alcohol consumption, education level, statin use, batch effects, percentage of lymphocytes, and percentage of neutrophils. Participants with diabetes were excluded.
Table 4. Mediation effect investigating whether blood ICAM-1 methylation mediates the association 
between air pollution and fasting blood glucose level. Indirect effect represents the mediated effect 
through the ICAM-1 methylation pathway.
PM2.5 concentration
Exposure to mediator 
association (βPM2.5)
Mediator to outcome 
association (γM)
Mediated effect of 
ICAM-1 methylation
Proportion 
mediated
1-day moving average 0.004 (–0.008, 0.008) –2.65 (–4.41, –0.89) –0.01 (–0.02, 0.004) —a
7-day moving average –0.0004 (–0.007, 0.006) –2.69 (–4.45, –0.93) 0.001 (–0.02, 0.02) 1%
28-day moving average –0.01 (–0.02, –0.004) –2.47 (–4.23, –0.72) 0.03 (0.0001, 0.06) 9%
Note: Estimates correspond to 1-μg/m3 increase in PM2.5 concentration.
Results from linear mixed-effects regression models accounting for correlation across multiple visits and adjusted for 
age, BMI, race, regular patterns of physical activity, smoking status, pack-years smoked, alcohol consumption, educa-
tion level, statin use, temperature, seasonality, batch effect, % of lymphocytes, and % of neutrophils. Participants with 
diabetes were excluded.
aProportion mediated cannot be estimated in this case because βPM2.5 and γM have opposite signs.
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(Yagi et al. 1995), which could affect beta-
cell function and result in impaired insulin 
secretion. Although the observed association 
was relatively modest, our estimates were 
comparable to many other studies evaluating 
the association between ambient air pollu-
tion and DNA methylation with similar 
exposure levels (Guo et al. 2014; Madrigano 
et al. 2011). DNA methylation is measured 
as a percentage, which indicates the propor-
tion of cells, or more accurately of haploid 
genomes, which show methylation at the 
sequence being analyzed. The differences in 
DNA methylation reported in our study are 
related to the presence upon PM2.5 exposure 
of higher numbers of circulating blood 
cells within no methylation at the ICAM-1 
promoter. Further research is needed to 
determine whether these cells correspond to 
a specific leukocyte population with known 
function and their potential roles in relation 
to PM2.5 effects.
Conversely, methylation on the cytokine 
genes investigated (i.e., IFN-γ and IL-6) was 
not implicated as a mediator in this study. 
Many pro- and anti-inflammatory cytokines 
act in concert to trigger the inflammatory 
cascade. Future research may expand the 
number of inflammatory cytokines investi-
gated and examine their joint effects.
One interesting aspect of the human 
methylome is that it exhibits both dynamic 
and static patterns. For instance, methylation 
of imprinted genes and genes drives tissue 
lineage commitment and differentiation 
that is established during embryogenesis and 
persists through life (Li et al. 1993); on the 
other hand, DNA methylation of inflamma-
tory genes may change rapidly after environ-
mental insults (Guo et al. 2014; Hou et al. 
2014; Tarantini et al. 2009). Our results 
are consistent with the dynamic nature of 
methylation levels in inflammatory pathways, 
which allows for fine tuning of inflamma-
tory responses. Nevertheless, we are aware 
that differences in DNA methylation do not 
necessarily translate into gene expression 
changes. DNA methylation is only one of 
the regulatory machineries that control gene 
expression. Other regulatory mechanisms, 
such a transcription factor activation, histone 
modification, chromatin remodeling and 
RNA silencing may also contribute to regula-
tion of gene expression at various stages.
This study has a number of strengths. 
We estimated concentrations of PM2.5 at 
the residential address for each participant 
using a state-of-art hybrid model. Estimates 
from this hybrid model serve as better surro-
gates relative to the standard use of data 
from monitoring stations for each partici-
pant’s actual exposure, and limit exposure 
misclassifications. We conducted analyses 
both on FBG as a continuous variable and 
on IFG, a dichotomized variable constructed 
using a well-established cutoff for preclinical 
alterations in glucose metabolism. These two 
sets of analyses produced highly consistent 
results. We used repeated measures, which 
were accounted for using linear mixed-effects 
models with subject specific intercepts for 
FBG and generalized linear equations (GEE) 
model with empirical variance for IFG. We 
conducted mediation analysis as a novel 
approach for DNA methylation studies. This 
approach is particularly useful for investi-
gating effects due to environmental exposures. 
While Mendelian randomization—a method 
that relies on genotype data used as instru-
mental variables—is often proposed to iden-
tifying epigenetic mediation, this approach 
cannot be used for external risk factors, such 
as PM, which, due to their nature, are not 
associated with the participants’ genetic 
sequences (such as single nucleotide poly-
morphisms) (Relton and Davey Smith 2012). 
Finally, we measured DNA methylation in 
candidate genes by pyrosequencing, which 
yields high precision (Tost and Gut 2007).
Our study has a few notable limitations. 
We focused on correlations among DNA 
methylation and FBG at the same clinical 
visit. It is therefore difficult to disentangle the 
temporal relationship between DNA methyla-
tion and FBG concentrations. However, when 
we examined the effect of DNA methyla-
tion on FBG for the subsequent visit (i.e., 
ICAM-1ij ≥ FBGij + 1), we did not find any 
association. We also found no association of 
FBG on ICAM-1 methylation at the subse-
quent visit (i.e., FBGij ≥ ICAM-1ij + 1). These 
analyses confirm that the effects we observed 
represent short- and medium-term responses 
to PM2.5 and are not persistent over the 
3–5 years between the medical visits. To 
obtain valid estimates for the natural indirect 
effects, we made the following assumptions: 
a) no-unmeasured confounding between 
PM2.5 concentration and FBG levels, 
b) no-unmeasured confounding between 
PM2.5 concentration and methylation, 
c) no-unmeasured confounding between meth-
ylation and FBG levels, and d) no methylation-
FBG confounders affected by the exposure. 
We conducted a number of sensitivity analyses 
to test the robustness to the no-unmeasured 
confounding assumptions. We excluded 
participants who were current smokers to 
better control for residual confounding by 
smoking; we additionally controlled for total 
calorie intake and glycemic index, to limit 
potential confounding from diet; we also 
restricted the analysis to participants with a 
CRP level < 10 mg/L, to partially remove 
potential effect from acute inflammation. In 
addition, we assessed the validity of assump-
tion d either based on subject knowledge or 
empirically (Bind et al. 2016). From previous 
subject knowledge, we assumed that PM2.5 
concentration would not affect participants’ 
age, race, smoking status, and statin use, as 
well as the batch of methyla tion measurements 
and seasonality. We also tested whether PM2.5 
concentration would influence participant’s 
BMI, regular patterns of physical activity, 
percentage of lymphocytes, and percentage of 
neutrophils, by regressing PM2.5 concentra-
tion on each of these potential confounders. 
None of the above mediator–outcome 
confounders in current analysis were affected 
by the exposure (p-values were 0.10, 0.54, 
0.50, and 0.78, respectively). Another limita-
tion of our study is the potential for measure-
ment error in both the exposure and FBG. 
However, we expect both measurement 
errors to be nondifferential and therefore to 
attenuate—rather than to cause—the observed 
significant associations.
Conclusion
In conclusion, we found that PM2.5 concen-
trations are associated with higher FBG level, 
and this association was in part mediated 
through ICAM-1 gene methylation, particu-
larly at the longer (28-day) moving average 
investigated. Our study demonstrates a novel 
approach of mediation analysis in epigenetic 
studies and highlights a mediating role of 
ICAM-1 gene methylation in air pollution–
associated abnormal glucose metabolism. 
While the proportion mediated by ICAM-1 
methylation alone is relatively modest, 
methylation of other genes not investigated 
in this study, independently or in combina-
tion with ICAM-1 methylation, may mediate 
larger proportions of PM2.5 effects. Future 
epigenome-wide studies are needed to deter-
mine the extent to which DNA methylation 
contributes to mediate environmental effects 
on human metabolism.
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